You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
九安醫療(002432.SZ):美國ACC追加採購1.04億人份iHealth試劑盒產品 總合同額增至17.75億美元
格隆匯 01-27 08:51

格隆匯1月27日丨九安醫療(002432.SZ)披露美國子公司日常經營重大合同的進展公吿。公司子公司iHealth Labs. Inc(簡稱“美國子公司”)與美國ACC(U.S.Army Contracting Command,美國陸軍合約管理指揮部)代表美國HHS(United States Department of Health and Human Services,美國衞生與公眾服務部)就iHealth新冠抗原家用自測OTC試劑盒產品(簡稱“iHealth試劑盒”)於當地時間2022年1月13日簽訂了《採購合同》(簡稱“合同”),採購iHealth試劑盒產品共計2.5億人份,合同價税合計金額為12.75億美元(含運費),約合人民幣81.02億元(按照2022年1月13日美元兑人民幣匯率中間價1美元=6.3542元人民幣計算)。

美國當地時間2022年1月26日,美國子公司與美國ACC就原《採購合同》簽署了《變更合同》,在原合同2.5億人份iHealth試劑盒產品的採購基礎上,再追加採購iHealth試劑盒產品約1.04億人份,由於上述變更事項,合同價税合計金額增加了約5.00億美元(不含運費)約合人民幣31.62億元(按照2022年1月26日美元兑人民幣匯率中間價1美元=6.3246元人民幣計算),總合同金額從12.75億美元增加至約17.75億美元約合人民幣112.26億元(按照2022年1月26日美元兑人民幣匯率中間價1美元=6.3246元人民幣計算)。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account